Back
Imunon Vs. Brainstorm Cell Therapeutics Industry Stock Comparison
Sell
24
IMNN
Imunon
Last Price:
0.93
Seasonality Move:
5.58%
Sell
7
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.88
Seasonality Move:
2.27%
Sell
24
Imunon (IMNN)
is a Sell
Is Imunon a Buy, Sell or Hold?
- The current Imunon [IMNN] share price is $0.93. The Score for IMNN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- IMNN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
7
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $1.87. The Score for BCLI is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IMNN Stock Price Chart
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $1.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
IMNN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 39.59 | Sell |
| Chaikin Money Flow: | -47657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.96 - 1.04) | Sell |
| Bollinger Bands (100): | (0.89 - 1.41) | Sell |
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 30.53 | Sell |
| Chaikin Money Flow: | -6697 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 2.88) | Sell |
| Bollinger Bands (100): | (2.96 - 5.76) | Sell |
IMNN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.95 | Sell |
| 20-day SMA: | 0.99 | Sell |
| 50-day SMA: | 1.05 | Sell |
| 200-day SMA: | 1.11 | Sell |
| 8-day EMA: | 0.95 | Sell |
| 20-day EMA: | 0.98 | Sell |
| 50-day EMA: | 1.05 | Sell |
| 200-day EMA: | 1.14 | Sell |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.97 | Sell |
| 20-day SMA: | 2.11 | Sell |
| 50-day SMA: | 3.3 | Sell |
| 200-day SMA: | 5.56 | Sell |
| 8-day EMA: | 1.99 | Sell |
| 20-day EMA: | 2.27 | Sell |
| 50-day EMA: | 3.11 | Sell |
| 200-day EMA: | 6.38 | Sell |
Imunon Earnings Growth & IMNN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.59 per share.
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Imunon Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Brainstorm Cell Therapeutics Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||